[HTML][HTML] Lymphocyte to monocyte ratio predicts survival and is epigenetically linked to miR-222-3p and miR-26b-5p in diffuse large B cell lymphoma
AM Metwally, AAHM Kasem, MI Youssif, SM Hassan… - Scientific Reports, 2023 - nature.com
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin
lymphoma. 10–20% of the patients present with bone marrow (BM) involvement which …
lymphoma. 10–20% of the patients present with bone marrow (BM) involvement which …
Lymphocyte to monocyte ratio predicts survival and is epigenetically linked to miR-222-3p and miR-26b-5p in diffuse large B cell lymphoma
AM Metwally, AAHM Kasem, MI Youssif… - Scientific …, 2023 - ui.adsabs.harvard.edu
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin
lymphoma. 10-20% of the patients present with bone marrow (BM) involvement which …
lymphoma. 10-20% of the patients present with bone marrow (BM) involvement which …
Lymphocyte to monocyte ratio predicts survival and is epigenetically linked to miR-222-3p and miR-26b-5p in diffuse large B cell lymphoma.
AM Metwally, A Kasem, MI Youssif, SM Hassan… - Scientific …, 2023 - europepmc.org
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin
lymphoma. 10-20% of the patients present with bone marrow (BM) involvement which …
lymphoma. 10-20% of the patients present with bone marrow (BM) involvement which …
[HTML][HTML] Lymphocyte to monocyte ratio predicts survival and is epigenetically linked to miR-222-3p and miR-26b-5p in diffuse large B cell lymphoma
AM Metwally, AAHM Kasem, MI Youssif… - Scientific …, 2023 - ncbi.nlm.nih.gov
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin
lymphoma. 10–20% of the patients present with bone marrow (BM) involvement which …
lymphoma. 10–20% of the patients present with bone marrow (BM) involvement which …
Lymphocyte to monocyte ratio predicts survival and is epigenetically linked to miR-222-3p and miR-26b-5p in diffuse large B cell lymphoma
AM Metwally, AAHM Kasem, MI Youssif… - Scientific …, 2023 - pubmed.ncbi.nlm.nih.gov
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin
lymphoma. 10-20% of the patients present with bone marrow (BM) involvement which …
lymphoma. 10-20% of the patients present with bone marrow (BM) involvement which …
Lymphocyte to monocyte ratio predicts survival and is epigenetically linked to miR-222-3p and miR-26b-5p in diffuse large B cell lymphoma.
AM Metwally, AAHM Kasem, MI Youssif… - Scientific …, 2023 - search.ebscohost.com
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin
lymphoma. 10–20% of the patients present with bone marrow (BM) involvement which …
lymphoma. 10–20% of the patients present with bone marrow (BM) involvement which …
[引用][C] Lymphocyte to monocyte ratio predicts survival and is epigenetically linked to miR‑222‑3p and miR‑26b‑5p in diffuse large B cell lymphoma
AM Metwally, AAHM Kasem, MI Youssif… - Scientific …, 2023 - europepmc.org
Materials and methods Study design. Forty newly diagnosed diffuse large B-cell lymphoma
(DLBCL) patients were involved in the study. At the time of sample retrieval, the patients had …
(DLBCL) patients were involved in the study. At the time of sample retrieval, the patients had …